"
According to the latest report published by Data Bridge Market Research, the Next-Generation Sequencing (NGS) Services Market
CAGR Value
As per Data Bridge Market Research Analysis the global next-generation sequencing (NGS) services market size was valued at USD 14.57 billion in 2025 and is expected to reach USD 71.51 billion by 2033, at a CAGR of 22.00% during the forecast period
The reliable Next-Generation Sequencing (NGS) Services Market research report includes a thorough analysis of the market drivers, restraints, threats, and opportunities while it also addresses the lucrative investment options for the market players in the coming years. Estimates at a global as well as regional level are offered by the analysts. The market size, revenue generated from the sales and technologies by various application segments are also evaluated in this marketing report. The report compiles widespread intelligence studies that explore almost every aspect of the global market. The data and information is extensively researched and analyzed in the large scale Next-Generation Sequencing (NGS) Services Market report to guide market players to improve their business planning and ensure long-term success.
Stay informed with our latest keyword market research covering strategies, innovations, and forecasts. Download full report: https://www.databridgemarketresearch.com/reports/global-ngs-services-market
Next-Generation Sequencing (NGS) Services Market Segmentation and Market Companies
Segments
- Based on the service type, the global NGS services market can be segmented into targeted sequencing, RNA sequencing, exome sequencing, whole genome sequencing, ChIP sequencing, de novo sequencing, and others. The targeted sequencing segment is expected to dominate the market due to its application in various research areas such as cancer, genetic disorders, and infectious diseases. RNA sequencing is also witnessing significant growth owing to its ability to provide valuable insights into gene expression patterns.
- On the basis of application, the NGS services market can be categorized into diagnostics, drug discovery, personalized medicine, agricultural and animal research, and others. The diagnostics segment holds a substantial share in the market as NGS services are widely used for identifying genetic mutations associated with diseases. In drug discovery, NGS services aid in identifying potential drug targets and biomarkers, driving the growth of this segment.
- By end-user, the market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and other end-users. The pharmaceutical and biotechnology companies segment is anticipated to witness significant growth due to the increasing adoption of NGS services for drug development and personalized medicine initiatives.
Market Players
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd
- Qiagen
- Eurofins Scientific
- PerkinElmer Inc.
- Genewiz
- Macrogen, Inc.
- GENEWIZ Germany GmbH
The global NGS services market is highly competitive, with key players focusing on strategic initiatives such as mergers, acquisitions, and partnerships to strengthen their market presence. The market players mentioned above are leading the market with their innovative products and services, extensive geographic presence, and strong customer base. These companies are investing heavily in research and development activities to launch advanced NGS services and maintain a competitive edge in the market.
The global Next-Generation Sequencing (NGS) services market is witnessing substantial growth and evolution driven by technological advancements and the increasing application of NGS in various fields such as diagnostics, drug discovery, and personalized medicine. As the demand for precision medicine and genomic research continues to rise, the market is projected to experience significant expansion in the coming years. One of the key trends shaping the market is the growing preference for targeted sequencing services, especially in research areas like cancer, genetic disorders, and infectious diseases. This preference can be attributed to the ability of targeted sequencing to provide focused and cost-effective analysis of specific genomic regions, making it a valuable tool for researchers and clinicians alike.
In terms of applications, the diagnostics segment is expected to maintain its dominance in the global NGS services market due to the increasing use of NGS technology for identifying genetic mutations associated with various diseases. The ability of NGS services to facilitate precise and comprehensive genetic analysis makes them well-suited for diagnostic purposes, enabling healthcare providers to offer personalized and effective treatment strategies. Moreover, the drug discovery segment is poised for significant growth as pharmaceutical and biotechnology companies leverage NGS services to accelerate drug development processes, identify potential drug targets, and discover biomarkers for various conditions. This trend is expected to drive demand for NGS services in the drug discovery sector, thereby fueling market growth.
From an end-user perspective, pharmaceutical and biotechnology companies are anticipated to be the key contributors to the growth of the NGS services market. These companies are increasingly adopting NGS technology for advancing drug development initiatives and personalized medicine approaches. By leveraging NGS services, pharmaceutical and biotechnology firms can enhance their research capabilities, optimize drug discovery processes, and improve patient outcomes through tailored treatment regimens. This growing adoption of NGS services among pharmaceutical and biotechnology companies underscores the significance of genomics in shaping the future of healthcare and precision medicine.
The competitive landscape of the global NGS services market is characterized by intense competition among key players such as Illumina, Inc., Thermo Fisher Scientific Inc., and Agilent Technologies, Inc. These market leaders are focused on expanding their market presence through strategic collaborations, acquisitions, and product innovations. By investing in research and development activities, these companies aim to introduce advanced NGS services that meet the evolving needs of researchers, clinicians, and other end-users. Overall, the global NGS services market is poised for lucrative opportunities and growth driven by technological advancements, expanding applications, and the increasing adoption of genomics in healthcare and research sectors.The Next-Generation Sequencing (NGS) services market is currently experiencing significant growth and transformation due to technological advancements and the expanding applications of NGS across various sectors. One notable trend in the market is the increasing preference for targeted sequencing services, specifically in research domains such as cancer, genetic disorders, and infectious diseases. Targeted sequencing offers a focused and cost-effective approach to analyzing specific genomic regions, thus becoming a valuable tool for researchers and clinicians seeking precise genetic insights.
In terms of applications, the diagnostics segment is expected to remain a dominant force in the global NGS services market. The utilization of NGS technology for identifying genetic mutations associated with different diseases is on the rise, given its ability to enable detailed genetic analysis for precise diagnostic purposes. NGS services empower healthcare providers to deliver personalized treatment strategies more effectively, thereby enhancing patient outcomes. Additionally, the drug discovery segment is poised for substantial growth as pharmaceutical and biotechnology companies leverage NGS services to streamline drug development processes, identify potential drug targets, and uncover biomarkers for various conditions. This heightened interest in NGS services for drug discovery is anticipated to stimulate market demand in this sector.
From an end-user standpoint, pharmaceutical and biotechnology companies are expected to play a pivotal role in propelling the growth of the NGS services market. These entities are increasingly embracing NGS technology to advance drug development initiatives and personalized medicine strategies. By leveraging NGS services, pharmaceutical and biotechnology firms can enhance their research capabilities, optimize drug discovery methodologies, and tailor treatment regimens to individual patient needs. The growing adoption of NGS services within the pharmaceutical and biotechnology sectors underscores the significant impact of genomics on healthcare and precision medicine advancements.
The competitive landscape of the global NGS services market is characterized by intense rivalry among key players like Illumina, Inc., Thermo Fisher Scientific Inc., and Agilent Technologies, Inc. These industry leaders are actively enhancing their market presence through strategic collaborations, acquisitions, and product innovations. By prioritizing research and development endeavors, these companies aim to introduce cutting-edge NGS services that cater to the evolving requirements of researchers, clinicians, and other end-users. Overall, the global NGS services market presents lucrative opportunities for growth driven by ongoing technological enhancements, the expanding scope of applications, and the escalating adoption of genomics in healthcare and research realms.
Frequently Asked Questions About This Report
How are Next-Generation Sequencing (NGS) Services Market companies reducing their water footprint?
What are the upcoming trends in the Next-Generation Sequencing (NGS) Services Market for sustainability?
What is the projected market valuation for the Next-Generation Sequencing (NGS) Services Market by 2033?
How much do the top 10 players contribute to the overall Next-Generation Sequencing (NGS) Services Market share?
What is the impact of Legacy Systems on the Next-Generation Sequencing (NGS) Services Market?
How do online reviews influence the Next-Generation Sequencing (NGS) Services Market?
What is the expected CAGR for the Next-Generation Sequencing (NGS) Services Market during the forecast period?
Which product type is expected to witness the fastest growth through 2033?
How is Greenwashing risk managed in the Next-Generation Sequencing (NGS) Services Market industry?
What is the investment feasibility of the Next-Generation Sequencing (NGS) Services Market?
What was the valuation of Next-Generation Sequencing (NGS) Services Market hardware in 2024?
What is the growth of Next-Generation Sequencing (NGS) Services Market in the Agriculture tech market?
Browse More Reports:
Global Next-Generation Sequencing (NGS) Services Market
Global Ship Repair and Maintenance Services Market
Global Hydroponics Market
Global Aerospace Parts Manufacturing Market
Global Smart Hospitality Market
Global Recovered Carbon Black (rCB) Market
Global Polypropylene Market
Global Freelance Platforms Market
Global E-Pharma Market
Global Frozen Yogurt Market
Global Bath and Shower Products Market
Global Carbon Capture, Utilization, and Storage Market
Global Quinoa Milk Market
Global Tungsten Carbide Powder Market
Global Pet Insurance Market
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 994
Email:- [email protected]"
Comments